Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Trimi Health vs Roen Rx

Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Roen Rx a 71. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Trimi Health

#3 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Trimi Health review →
VS

Roen Rx

#229 · Grade C · Watch List

Est. first month

From $151/mo (3-month plan, plus a separate fee, compounded)

Save ~89% vs brand-name
Get this deal Full Roen Rx review →

The verdict

Better value: Trimi Health

Trimi Health takes it on Value Score, 89 to 71 an est. $99/mo first month, with no teaser step-up baked in. Roen Rx isn't out of it: Patients with insurance seeking brand-name GLP-1 access with compounded fallback.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealTrimi HealthRoen Rx
Value Score89 (A)71 (C)
Est. first month$99/moFrom $151/mo (3-month plan, plus a separate fee, compounded)
Save vs brand-name~93%~89%
Semaglutide$99/moFrom $151/mo (3-month plan, plus a separate fee, compounded)
Tirzepatide$125/moFrom $216/mo (medication billed separately, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
82
Trimi Health: 95. Roen Rx: 82.
84
No Teaser-Rate Bait
62
Trimi Health: 84. Roen Rx: 62.
98
Nationwide Availability
45
Trimi Health: 98. Roen Rx: 45.
94
Both Molecules
92
Trimi Health: 94. Roen Rx: 92.
82
Easy Cancellation
54
Trimi Health: 82. Roen Rx: 54.
70
Reputation
73
Trimi Health: 70. Roen Rx: 73.

Trimi Health

The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.

Why it's a deal

  • Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
  • Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
  • Nationwide 50-state reach, so the low price isn't gated to a handful of states

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
  • Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
  • Newer brand with a thin public track record

Roen Rx

Roen Rx offers compounded semaglutide as well as brand-name Ozempic, Wegovy, Zepbound, and Mounjaro with insurance coordination.

Why it's a deal

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • Both compounded and brand-name options
  • LegitScript approved with Compounded USA badge
  • Compounded semaglutide from $151/mo quarterly
  • Also offers primary care, mental health, and other specialties

The fine print

  • State availability not publicly disclosed
  • Insurance coordination may not work for all plans
  • Broader platform (ED, hair loss, skincare, birth control)
  • Requires a separate membership (first month $39); GLP-1 medications are NOT included in the membership fee - medication is billed on top
Get the Trimi Health deal Get the Roen Rx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Roen Rx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.